Logo image of BIG1.DE

BIO-GATE AG (BIG1.DE) Stock Price, Quote, News and Overview

FRA:BIG1 - Deutsche Boerse Ag - DE000BGAG981 - Common Stock - Currency: EUR

1.04  +0.03 (+2.97%)

BIG1.DE Quote, Performance and Key Statistics

BIO-GATE AG

FRA:BIG1 (6/2/2025, 7:00:00 PM)

1.04

+0.03 (+2.97%)

Sector
GICS SectorMaterials
GICS IndustryChemicals
GICS IndustryGroupMaterials
GICS SubIndustrySpecialty Chemicals
Statistics
52 Week High1.45
52 Week Low0.56
Market Cap9.61M
Shares9.24M
Float3.48M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)09-08 2025-09-08
IPO04-05 2006-04-05


BIG1.DE short term performance overview.The bars show the price performance of BIG1.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 20 40 60

BIG1.DE long term performance overview.The bars show the price performance of BIG1.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 -20 -40 -60

The current stock price of BIG1.DE is 1.04 EUR. In the past month the price increased by 30%. In the past year, price increased by 1.96%.

BIO-GATE AG / BIG1 Daily stock chart

BIG1.DE Competitors/Peers

The largest stocks on the EU markets in the "Specialty Chemicals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
GIN.DE GIVAUDAN-REG 34.27 40.84B
SIKA.DE SIKA AG-REG 28.02 37.28B
DSFIR.AS DSM-FIRMENICH AG 103.94 25.96B
6D81.DE DUPONT DE NEMOURS INC 15.58 24.72B
BRG.OL BORREGAARD ASA 21.48 18.82B
SY1.DE SYMRISE AG 31.15 14.89B
ELK.OL ELKEM ASA 17.61 12.84B
1COV.DE COVESTRO AG N/A 11.36B
AKZA.AS AKZO NOBEL N.V. 16.06 10.18B
EVK.DE EVONIK INDUSTRIES AG 29.78 8.88B
SYENS.BR SYENSQO SA 14.52 7.20B
AMC.DE ALBEMARLE CORP N/A 5.84B

About BIG1.DE

Company Profile

BIG1 logo image Bio-Gate AG engages in the development and production of technologies and solutions for health and hygiene, primarily used in orthopedics, traumatology, and vascular surgery. The company is headquartered in Nuremberg, Bayern. The company went IPO on 2006-04-05. The firm employs silver technology to endow materials and products with antimicrobial properties, and specializes in plasmacoating, spray, additives and textile solutions, among others. The company produces medical technology products, as well as technologies to refine cosmetics, consumer goods and industrial products. Its products are applied in the area of implants, skin care, cosmetics, orthopedics, industrial applications, consumer goods, would care, textiles and dental products. The firm incorporates silver particles into cosmetics, paints, veneers or plastics, or involves coating of final products, such as implants or wound dressings, with a silver-containing functional layer.

Company Info

BIO-GATE AG

Neumeyerstrasse 28-34

Nuremberg BAYERN DE

Employees: 45

BIG1 Company Website

BIG1 Investor Relations

Phone: 49911477523100

BIO-GATE AG / BIG1.DE FAQ

What is the stock price of BIO-GATE AG today?

The current stock price of BIG1.DE is 1.04 EUR. The price increased by 2.97% in the last trading session.


What is the ticker symbol for BIO-GATE AG stock?

The exchange symbol of BIO-GATE AG is BIG1 and it is listed on the Deutsche Boerse Ag exchange.


On which exchange is BIG1.DE stock listed?

BIG1.DE stock is listed on the Deutsche Boerse Ag exchange.


What is the price forecast or stock price prediction for BIO-GATE AG stock?

8 analysts have analysed BIG1.DE and the average price target is 3.37 EUR. This implies a price increase of 223.65% is expected in the next year compared to the current price of 1.04. Check the BIO-GATE AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is BIO-GATE AG worth?

BIO-GATE AG (BIG1.DE) has a market capitalization of 9.61M EUR. This makes BIG1.DE a Nano Cap stock.


How many employees does BIO-GATE AG have?

BIO-GATE AG (BIG1.DE) currently has 45 employees.


What are the support and resistance levels for BIO-GATE AG (BIG1.DE) stock?

BIO-GATE AG (BIG1.DE) has a support level at 0.65. Check the full technical report for a detailed analysis of BIG1.DE support and resistance levels.


Is BIO-GATE AG (BIG1.DE) expected to grow?

The Revenue of BIO-GATE AG (BIG1.DE) is expected to grow by 4.65% in the next year. Check the estimates tab for more information on the BIG1.DE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy BIO-GATE AG (BIG1.DE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does BIO-GATE AG (BIG1.DE) stock pay dividends?

BIG1.DE does not pay a dividend.


When does BIO-GATE AG (BIG1.DE) report earnings?

BIO-GATE AG (BIG1.DE) will report earnings on 2025-09-08.


What is the Price/Earnings (PE) ratio of BIO-GATE AG (BIG1.DE)?

BIO-GATE AG (BIG1.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.22).


BIG1.DE Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to BIG1.DE. When comparing the yearly performance of all stocks, BIG1.DE is one of the better performing stocks in the market, outperforming 91.38% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

BIG1.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to BIG1.DE. While BIG1.DE seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BIG1.DE Financial Highlights

Over the last trailing twelve months BIG1.DE reported a non-GAAP Earnings per Share(EPS) of -0.22. The EPS decreased by -33.87% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -45.48%
ROE -87.45%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-40.55%
Sales Q2Q%9.42%
EPS 1Y (TTM)-33.87%
Revenue 1Y (TTM)14.27%

BIG1.DE Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to BIG1.DE. The Buy consensus is the average rating of analysts ratings from 8 analysts.

For the next year, analysts expect an EPS growth of -37.5% and a revenue growth 4.65% for BIG1.DE


Ownership
Inst OwnersN/A
Ins Owners9.8%
Short Float %N/A
Short RatioN/A
Analysts
Analysts82.5
Price Target3.37 (224.04%)
EPS Next Y-37.5%
Revenue Next Year4.65%